Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Institute of Immunology
Tokyo, Japantokumen.co.jp ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Institute of Immunology manufactures and sells diagnostic reagents, monoclonal antibodies, and antigens, produces genetically engineered animals and cells, and develops unique animal models (notably for in vivo antibody drug evaluation). They have decades of operational history and support life science R&D, including preclinical models.
- Therapeutic areas
- OncologyInfectious DiseasesImmunology
- Modalities
- Monoclonal antibodyRecombinant proteinCell therapyAnimal modeliPS cell derived therapyDiagnostic reagents
- Industry
- Drug Discovery Services
Beyond the preview
Go deeper on Institute of Immunology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Institute of Immunology.